| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.68B | — | +27.5% |
| Cost of Revenue | $1.45B | — | +24.2% |
| Gross Profit | $239.0M | — | +51.7% |
| R&D Expense | $41.8M | — | -8.5% |
| SG&A Expense | $97.0M | — | +20.6% |
| Operating Income | $100.3M | — | +218.1% |
| Pre-tax Income | $96.3M | — | +273.4% |
| Income Tax | $12.3M | — | +213.6% |
| Net Income | $83.4M | — | +294.5% |
| EPS (Basic) | $0.34 | — | +277.8% |
| EPS (Diluted) | $0.33 | — | +266.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.12B | -18.7% | +6.0% |
| Short-term Investments | $727.3M | +18.6% | +44.0% |
| Accounts Receivable | $1.29B | -4.9% | +22.3% |
| Inventory | $494.6M | +13.0% | +51.6% |
| Current Assets | $3.75B | -3.4% | +25.4% |
| Total Assets | $8.30B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $145.1M | — | +500.8% |
| Capital Expenditures | $224.6M | — | +181.1% |
| Investing Cash Flow | -$334.7M | — | -430.8% |
| Financing Cash Flow | -$67.0M | — | -58.7% |
| Free Cash Flow | -$79.5M | — | -42.6% |
| +19.9% |
| Current Liabilities | $1.87B | +9.0% | +28.4% |
| Long-term Debt | $1.26B | -2.0% | +37.7% |
| Total Liabilities | $3.73B | +2.7% | +36.6% |
| Stockholders' Equity | $4.53B | +1.4% | +9.1% |